More SEC Filings
View Older Stories View Newer Stories-
Form 8-K Matador Resources Co For: Apr 09
-
Form DEF 14A HONEYWELL INTERNATIONAL For: May 20
-
Form 13F-HR Czech National Bank For: Mar 31
-
Form 8-K SONO TEK CORP For: Apr 09
-
Form 6-K Primega Group Holdings For: Apr 09
-
Form 8-K NEOGEN CORP For: Apr 08
-
Form 6-K Valneva SE For: Dec 31
-
Form 8-K Tonix Pharmaceuticals For: Apr 09
-
Form 6-K Triple Flag Precious For: Apr 09
-
Form 10-K Digital Brands Group, For: Dec 31
-
Form 6-K Bilibili Inc. For: Apr 09
-
Form 6-K FIRST MAJESTIC SILVER For: Apr 09
-
Form 8-K Simply Good Foods Co For: Apr 09
-
Form DEF 14A CRAWFORD UNITED Corp For: May 22
-
Form 8-K Post Holdings, Inc. For: Mar 26
-
Form 425 Aerovate Therapeutics, Filed by: Aerovate Therapeutics, Inc.
-
Form 8-K NEOGEN CORP For: Apr 09
-
Form 8-K Aerovate Therapeutics, For: Apr 09
-
Form 3/A SBC Medical Group Holdin For: Sep 17 Filed by: Aikawa Yoshiyuki
-
Form 6-K GILAT SATELLITE NETWORKS For: Apr 09
-
Form DEFA14A HBT Financial, Inc.
-
Form DEF 14A HBT Financial, Inc. For: May 20
-
Form 8-K Walmart Inc. For: Apr 09
-
Form DEFR14A DT Cloud Acquisition
-
Form 6-K Haleon plc For: Apr 09
-
Form 6-K ENDEAVOUR SILVER CORP For: Apr 09
-
Form ARS Rithm Capital Corp. For: Dec 31
-
Form DEFA14A Rithm Capital Corp.
-
Form 424B2 BofA Finance LLC
-
Form DEFA14A Ingredion Inc
-
Form DEF 14A Ingredion Inc For: Apr 09
-
Form DEF 14A Rithm Capital Corp. For: May 22
-
Form SC 14D9/A Global Blue Group Holdin Filed by: Global Blue Group Holding AG
-
Form 424B2 BofA Finance LLC
-
Form 6-K GSK plc For: Apr 09
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K TherapeuticsMD, Inc. For: Apr 08
-
Form 424B2 Neuberger Berman High
-
Form 8-K DELTA AIR LINES, INC. For: Apr 09
-
Form S-1/A Origin Investment Corp
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 425 Aimfinity Investment Filed by: Aimfinity Investment Merger Sub I
-
Form S-1/A Reliance Global Group,
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K Ellomay Capital Ltd. For: Apr 09
-
Form S-1 Aspire Biopharma Holding
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 MORGAN STANLEY

